Predicting drug-target interactions using restricted Boltzmann machines

Bioinformatics

Volumn 29, Issue 13, 2013, Pages

  Wang, Yuhao ^a   Zeng, Jianyang ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; PROTEIN;

ALGORITHM; ARTICLE; ARTIFICIAL INTELLIGENCE; COMPUTER SIMULATION; DRUG DEVELOPMENT; DRUG EFFECT; DRUG REPOSITIONING; HUMAN; METABOLISM; METHODOLOGY; DRUG EFFECTS; PROCEDURES;

ALGORITHMS; ARTIFICIAL INTELLIGENCE; COMPUTER SIMULATION; DRUG DISCOVERY; DRUG REPOSITIONING; HUMANS; PHARMACEUTICAL PREPARATIONS; PROTEINS;

EID: 84879970943     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btt234     Document Type: Conference Paper

References (53)

1. Arel, I. et al. (2010) Deep machine learning-a new frontier in artificial intelligence research. IEEE Comput. Intell. Mag., 5, 13-18.
2. Bell, R. and Koren, Y. (2007) Lessons from the netflix prize challenge. ACM SIGKDD Explor. Newsl., 9, 75-79.
3. Bengio, Y. (2009) Learning deep architectures for AI. Found. Trends Mach. Learn., 2, 1-127.
4. Bleakley, K. and Yamanishi, Y. (2009) Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics, 25, 2397-2403.
5. Booth, B. and Zemmel, R. (2004) Prospects for productivity. Nat. Rev. Drug. Discov., 3, 451-456.
6. Campillos, M. et al. (2008) Drug target identification using side-effect similarity. Science, 321, 263-266.
7. Chen, X. et al. (2012) Drug-target interaction prediction by random walk on the heterogeneous network. Mol. Biosyst., 8, 1970-1978.
8. Cheng, A.C. et al. (2007) Structure-based maximal affinity model predicts smallmolecule druggability. Nat. Biotechnol., 25, 71-75.
9. Cheng, F. et al. (2012) Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput. Biol., 8, e1002503.
10. Davis, J. and Goadrich, M. (2006) The relationship between precision-recall and roc curves. In: Proceedings of the 23rd international conference on Machine learning, ICML'06. ACM, New York, NY, USA, pp. 233-240.
11. Dimasi, J.A. (2001) New drug development in the united states from 1963 to 1999. Clin. Pharmacol. Ther., 69, 286-296.
12. Donald, B.R. (2011) Algorithms in Structural Molecular Biology. MIT Press, Cambridge, MA, USA.
13. Dudley, J.T. et al. (2011) Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci. Transl. Med., 3, 96ra76.
14. Eickholt, J. and Cheng, J. (2012) Predicting protein residue-residue contacts using deep networks and boosting. Bioinformatics, 28, 3066-3072.
15. Gaulton, A. et al. (2011) ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Res., 40, D1100-D1107.
16. Gottlieb, A. et al. (2011) PREDICT: A method for inferring novel drug indications with application to personalized medicine. Mol. Syst. Biol., 7, 496.
17. Gottlieb, A. et al. (2012) INDI: A computational framework for inferring drug interactions and their associated recommendations. Mol. Syst. Biol., 8, 592.
18. Günther, S. et al. (2008) SuperTarget and Matador: Resources for exploring drugtarget relationships. Nucleic Acids Res., 36, D919-D922.
19. Haeggström, J.Z. (2000) Structure, function, and regulation of leukotriene A4 hydrolase. Am. J. Respir. Crit. Care. Med., 161, S25-S31.
20. He, Z. et al. (2010) Predicting drug-target interaction networks based on functional groups and biological features. PLoS One, 5, e9603.
21. Hinton, G. and Salakhutdinov, R. (2006) Reducing the dimensionality of data with neural networks. Science, 28, 504-507.
22. Hinton, G.E. (2002) Training products of experts by minimizing contrastive divergence. Neural Comput., 14, 1771-1800.
23. Iorio, F. et al. (2010) Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc. Natl Acad. Sci. USA, 107, 14621-14626.
24. Jiang, J. et al. (2007) Effects of mifepristone on expression of estrogen receptor and progesterone receptor in cultured human eutopic and ectopic endometria. Zhonghua Fu Chan Ke Za Zhi, 36, 218-221.
25. Kaiser, J. (2005) Science resources. chemists want NIH to curtail database. Science, 308, 774.
26. Keiser, M.J. et al. (2007) Relating protein pharmacology by ligand chemistry. Nat. Biotechnol., 25, 197-206.
27. Keiser, M.J. et al. (2009) Predicting new molecular targets for known drugs. Nature, 462, 175-181.
28. Knox, C. et al. (2011) DrugBank 3.0: A comprehensive resource for 'omics' research on drugs. Nucleic Acids Res., 39, D1035-D1041.
29. Kroeze, W.K. et al. (2002) Molecular biology of serotonin receptors structure and function at the molecular level. Curr. Top. Med. Chem., 2, 507-528.
30. Kuhn, M. et al. (2012) STITCH 3: Zooming in on protein-chemical interactions. Nucleic Acids Res., 40, D876-D880.
31. Larochelle, H. and Bengio, Y. (2008) Classification using discriminative restricted boltzmann machines. In: Proceedings of the 25th international conference on Machine learning, ICML'08. ACM, New York, NY, USA, pp. 536-543.
32. Le Roux, N. and Bengio, Y. (2008) Representational power of restricted boltzmann machines and deep belief networks. Neural Comput., 20, 1631-1649.
33. Lü, L. and Zhou, T. (2011) Link prediction in complex networks: A survey. Physica A Stat. Mech. Appl., 390, 1150-1170.
34. Macdonald, F. (1997) Dictionary of Pharmacological Agents. CRC Press, Taylor and Francis Group, LLC, Boca Raton, FL, USA.
35. MacDonald, M.L. et al. (2006) Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat. Chem. Biol., 2, 329-337.
36. Mei, J.P. et al. (2012) Drug-target interaction prediction by learning from local information and neighbors. Bioinformatics, 29, 238-245.
37. Mizutani, S. et al. (2012) Relating drug-protein interaction network with drug side effects. Bioinformatics, 28, i522-i528.
38. Morris, G.M. et al. (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem., 30, 2785-2791.
39. Nakhjavani, M. et al. (2009) Short term effects of spironolactone on blood lipid profile: A 3-month study on a cohort of young women with hirsutism. Br. J. Clin. Pharmacol., 68, 634-637.
40. Perlman, L. et al. (2011) Combining drug and gene similarity measures for drugtarget elucidation. J. Comput. Biol., 18, 133-145.
41. Roth, B.L. et al. (2004)Magic shotguns versus magic bullets: Selectively non-selective drugs for mood disorders and schizophrenia. Nat. Rev. Drug Discov., 3, 353-359.
42. Rudberg, P.C. et al. (2004) Leukotriene A4 hydrolase: Identification of a common carboxylate recognition site for the epoxide hydrolase and aminopeptidase substrates. J. Biol. Chem., 279, 27376-27382.
43. Salakhutdinov, R. et al. (2007) Restricted boltzmann machines for collaborative filtering. In: Proceedings of the 24th international conference onMachine learning, ICML'07. ACM, New York, NY, USA, pp. 791-798.
44. Sandborn, W.J. et al. (2007) Medical management of mild to moderate crohn's disease: Evidence-based treatment algorithms for induction and maintenance of remission. Aliment Pharmacol. Ther., 26, 987-1003.
45. Sirota, M. et al. (2011) Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci. Transl. Med., 3, 96ra77.
46. Tatonetti, N.P. et al. (2012) Data-driven prediction of drug effects and interactions. Sci. Transl. Med., 4, 125-131.
47. Van Laarhoven, T. et al. (2011) Gaussian interaction profile kernels for predicting drug-target interaction. Bioinformatics, 27, 3036-3043.
48. Welling, M. and Hinton, G. (2002) A new learning algorithm for mean field boltzmann machines. Artif. Neural Netw., 2415, 351-357.
49. Xia, Z. et al. (2010) Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces. BMC Syst. Biol., 4 (Suppl. 2), S6.
50. Xie, L. et al. (2012) Novel computational approaches to polypharmacology as a means to define responses to individual drugs. Annu. Rev. Pharmacol. Toxicol., 52, 361-379.
51. Yabuuchi, H. et al. (2011) Analysis of multiple compound-protein interactions reveals novel bioactive molecules. Mol. Syst. Biol., 7, 472.
52. Yamanishi, Y. et al. (2008) Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics, 24, i232-i240.
53. Zhao, S. and Li, S. (2010) Network-based relating pharmacological and genomic spaces for drug target identification. PLoS One, 5, e11764.